These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Secondary tricuspid regurgitation: Do we understand what we would like to treat?
    Author: Guérin A, Dreyfus J, Le Tourneau T, Sportouch C, Lairez O, Eicher JC, Flécher E, Réant P, Donal E.
    Journal: Arch Cardiovasc Dis; 2019 Oct; 112(10):642-651. PubMed ID: 31351805.
    Abstract:
    Tricuspid regurgitation has long been a neglected and underestimated entity; its prevalence is significant, and is increasing with the ageing population. Tricuspid regurgitation is often a consequence of chronic left cardiac pathologies or atrial fibrillation. Surgical treatment is recommended for patients with severe symptomatic tricuspid regurgitation or tricuspid annulus dilatation at the time of left heart valve surgery. Secondary tricuspid regurgitation is a complex disease; this review focuses on the need for better understanding of its mechanisms and quantification - mandatory with the advent of new percutaneous treatments.
    [Abstract] [Full Text] [Related] [New Search]